Research ExplorerPublicationsHistory of viral suppression on combination antiretroviral t...

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

Standard

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. / Reekie, J; Mocroft, A; Ledergerber, B; Beniowski, M; Clotet, B; van Lunzen, Jan; Chiesi, A; Pradier, C; Machala, L; Lundgren, J D; Group, EuroSIDA Study.

In: HIV MED, Vol. 11, No. 7, 7, 2010, p. 469-478.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Reekie, J, Mocroft, A, Ledergerber, B, Beniowski, M, Clotet, B, van Lunzen, J, Chiesi, A, Pradier, C, Machala, L, Lundgren, JD & Group, EIDAS 2010, 'History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.', HIV MED, vol. 11, no. 7, 7, pp. 469-478. <http://www.ncbi.nlm.nih.gov/pubmed/20201975?dopt=Citation>

APA

Reekie, J., Mocroft, A., Ledergerber, B., Beniowski, M., Clotet, B., van Lunzen, J., Chiesi, A., Pradier, C., Machala, L., Lundgren, J. D., & Group, EIDA. S. (2010). History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV MED, 11(7), 469-478. [7]. http://www.ncbi.nlm.nih.gov/pubmed/20201975?dopt=Citation

Vancouver

Reekie J, Mocroft A, Ledergerber B, Beniowski M, Clotet B, van Lunzen J et al. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. HIV MED. 2010;11(7):469-478. 7.

Bibtex

@article{c2add241e03644999bd6ee85b6531aa5,
title = "History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.",
abstract = "HIV-infected persons experience different patterns of viral suppression after initiating combination antiretroviral therapy (cART). The relationship between such differences and risk of virological failure after starting a new antiretroviral could help with patient monitoring strategies.",
keywords = "Adult, Humans, Male, Female, Middle Aged, Epidemiologic Methods, dosage, Time Factors, Disease Progression, CD4 Lymphocyte Count, Viral Load, Europe epidemiology, Treatment Failure, Medication Adherence, Drug Therapy, Combination, Anti-Retroviral Agents administration, Drug Resistance, Multiple, Viral, HIV Infections drug therapy, HIV-1 drug effects, RNA, Viral blood, Adult, Humans, Male, Female, Middle Aged, Epidemiologic Methods, dosage, Time Factors, Disease Progression, CD4 Lymphocyte Count, Viral Load, Europe epidemiology, Treatment Failure, Medication Adherence, Drug Therapy, Combination, Anti-Retroviral Agents administration, Drug Resistance, Multiple, Viral, HIV Infections drug therapy, HIV-1 drug effects, RNA, Viral blood",
author = "J Reekie and A Mocroft and B Ledergerber and M Beniowski and B Clotet and {van Lunzen}, Jan and A Chiesi and C Pradier and L Machala and Lundgren, {J D} and Group, {EuroSIDA Study}",
year = "2010",
language = "Deutsch",
volume = "11",
pages = "469--478",
journal = "HIV MED",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "7",

}

RIS

TY - JOUR

T1 - History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

AU - Reekie, J

AU - Mocroft, A

AU - Ledergerber, B

AU - Beniowski, M

AU - Clotet, B

AU - van Lunzen, Jan

AU - Chiesi, A

AU - Pradier, C

AU - Machala, L

AU - Lundgren, J D

AU - Group, EuroSIDA Study

PY - 2010

Y1 - 2010

N2 - HIV-infected persons experience different patterns of viral suppression after initiating combination antiretroviral therapy (cART). The relationship between such differences and risk of virological failure after starting a new antiretroviral could help with patient monitoring strategies.

AB - HIV-infected persons experience different patterns of viral suppression after initiating combination antiretroviral therapy (cART). The relationship between such differences and risk of virological failure after starting a new antiretroviral could help with patient monitoring strategies.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Epidemiologic Methods

KW - dosage

KW - Time Factors

KW - Disease Progression

KW - CD4 Lymphocyte Count

KW - Viral Load

KW - Europe epidemiology

KW - Treatment Failure

KW - Medication Adherence

KW - Drug Therapy, Combination

KW - Anti-Retroviral Agents administration

KW - Drug Resistance, Multiple, Viral

KW - HIV Infections drug therapy

KW - HIV-1 drug effects

KW - RNA, Viral blood

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Epidemiologic Methods

KW - dosage

KW - Time Factors

KW - Disease Progression

KW - CD4 Lymphocyte Count

KW - Viral Load

KW - Europe epidemiology

KW - Treatment Failure

KW - Medication Adherence

KW - Drug Therapy, Combination

KW - Anti-Retroviral Agents administration

KW - Drug Resistance, Multiple, Viral

KW - HIV Infections drug therapy

KW - HIV-1 drug effects

KW - RNA, Viral blood

M3 - SCORING: Zeitschriftenaufsatz

VL - 11

SP - 469

EP - 478

JO - HIV MED

JF - HIV MED

SN - 1464-2662

IS - 7

M1 - 7

ER -